Contrasting NovelStem International (NSTM) and Its Peers

NovelStem International (OTCMKTS:NSTM) is one of 26 public companies in the “Retail stores, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare NovelStem International to related businesses based on the strength of its dividends, risk, analyst recommendations, valuation, earnings, profitability and institutional ownership.

Risk & Volatility

NovelStem International has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, NovelStem International’s competitors have a beta of 0.82, meaning that their average stock price is 18% less volatile than the S&P 500.

Profitability

This table compares NovelStem International and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NovelStem International	-9,166.67%	N/A	-73.18%
NovelStem International Competitors	-25.06%	-60.82%	-0.94%

Insider and Institutional Ownership

29.3% of shares of all “Retail stores, not elsewhere classified” companies are owned by institutional investors. 13.6% of NovelStem International shares are owned by insiders. Comparatively, 16.9% of shares of all “Retail stores, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for NovelStem International and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovelStem International	0	0	0	0	N/A
NovelStem International Competitors	88	811	1393	56	2.60

As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 12.67%. Given NovelStem International’s competitors higher possible upside, analysts plainly believe NovelStem International has less favorable growth aspects than its competitors.

Valuation & Earnings

This table compares NovelStem International and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NovelStem International	$10,000.00	-$4.19 million	-0.30
NovelStem International Competitors	$49.55 billion	$125.40 million	6.40

NovelStem International’s competitors have higher revenue and earnings than NovelStem International. NovelStem International is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

NovelStem International competitors beat NovelStem International on 9 of the 10 factors compared.

NovelStem International Company Profile

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.